1. Moore TA, Wilson ME. Feeding intolerance: a concept analysis. Adv Neonatal Care. 2011; 11:149–154.
2. Berseth CL, Nordyke CK, Valdes MG, Furlow BL, Go VL. Responses of gastrointestinal peptides and motor activity to milk and water feedings in preterm and term infants. Pediatr Res. 1992; 31:587–590.
Article
3. Stoll BJ, Hansen N, Fanaroff AA, Wright LL, Carlo WA, Ehrenkranz RA, et al. Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network. Pediatrics. 2002; 110:285–291.
Article
4. Stoll BJ, Hansen NI, Adams-Chapman I, Fanaroff AA, Hintz SR, Vohr B, et al. Neurodevelopmental and growth impairment among extremely low-birth-weight infants with neonatal infection. JAMA. 2004; 292:2357–2365.
Article
6. Mansi Y, Abdelaziz N, Ezzeldin Z, Ibrahim R. Randomized controlled trial of a high dose of oral erythromycin for the treatment of feeding intolerance in preterm infants. Neonatology. 2011; 100:290–294.
Article
7. Indrio F, Riezzo G, Cavallo L, Di Mauro A, Francavilla R. Physiological basis of food intolerance in VLBW. J Matern Fetal Neonatal Med. 2011; 24:Suppl 1. 64–66.
Article
8. Lebenthal E, Lee PC, Heitlinger LA. Impact of development of the gastrointestinal tract on infant feeding. J Pediatr. 1983; 102:1–9.
Article
9. Fanaro S. Feeding intolerance in the preterm infant. Early Hum Dev. 2013; 89:Suppl 2. S13–S20.
Article
10. Hyman PE, Clarke DD, Everett SL, Sonne B, Stewart D, Harada T, et al. Gastric acid secretory function in preterm infants. J Pediatr. 1985; 106:467–471.
Article
11. Hyman PE, Feldman EJ, Ament ME, Byrne WJ, Euler AR. Effect of enteral feeding on the maintenance of gastric acid secretory function. Gastroenterology. 1983; 84:341–345.
Article
12. Mihatsch WA, Franz AR, Högel J, Pohlandt F. Hydrolyzed protein accelerates feeding advancement in very low birth weight infants. Pediatrics. 2002; 110:1199–1203.
Article
13. Raimondi F, Spera AM, Sellitto M, Landolfo F, Capasso L. Amino acid-based formula as a rescue strategy in feeding very-low-birth-weight infants with intrauterine growth restriction. J Pediatr Gastroenterol Nutr. 2012; 54:608–612.
Article
14. Fagerhol MK, Dale I, Andersson T. A radioimmunoassay for a granulocyte protein as a marker in studies on the turnover of such cells. Bull Eur Physiopathol Respir. 1980; 16:Suppl. 273–282.
Article
15. Lamb CA, Mansfield JC. Measurement of faecal calprotectin and lactoferrin in inflammatory bowel disease. Frontline Gastroenterol. 2011; 2:13–18.
Article
16. Moussa R, Khashana A, Kamel N, Elsharqawy SE. Fecal calprotectin levels in preterm infants with and without feeding intolerance. J Pediatr (Rio J). 2016; 92:486–492.
Article
17. Pergialiotis V, Konstantopoulos P, Karampetsou N, Koutaki D, Gkioka E, Perrea DN, et al. Calprotectin levels in necrotizing enterocolitis: a systematic review of the literature. Inflamm Res. 2016; 65:847–852.
Article
18. Kapel N, Campeotto F, Kalach N, Baldassare M, Butel MJ, Dupont C. Faecal calprotectin in term and preterm neonates. J Pediatr Gastroenterol Nutr. 2010; 51:542–547.
Article
19. Lim JS, Lim SW, Ahn JH, Song BS, Shim KS, Hwang IT. New Korean reference for birth weight by gestational age and sex: data from the Korean Statistical Information Service (2008–2012). Ann Pediatr Endocrinol Metab. 2014; 19:146–153.
Article
20. Li F, Ma J, Geng S, Wang J, Ren F, Sheng X. Comparison of the different kinds of feeding on the level of fecal calprotectin. Early Hum Dev. 2014; 90:471–475.
Article
21. Zoppelli L, Güttel C, Bittrich HJ, Andrée C, Wirth S, Jenke A. Fecal calprotectin concentrations in premature infants have a lower limit and show postnatal and gestational age dependence. Neonatology. 2012; 102:68–74.
Article
22. Rougé C, Butel MJ, Piloquet H, Ferraris L, Legrand A, Vodovar M, et al. Fecal calprotectin excretion in preterm infants during the neonatal period. PLoS One. 2010; 5:e11083.
Article
23. Savino F, Castagno E, Calabrese R, Viola S, Oggero R, Miniero R. High faecal calprotectin levels in healthy, exclusively breast-fed infants. Neonatology. 2010; 97:299–304.
Article
24. Campeotto F, Kalach N, Lapillonne A, Butel MJ, Dupont C, Kapel N. Time course of faecal calprotectin in preterm newborns during the first month of life. Acta Paediatr. 2007; 96:1531–1533.
Article
25. Yang Q, Smith PB, Goldberg RN, Cotten CM. Dynamic change of fecal calprotectin in very low birth weight infants during the first month of life. Neonatology. 2008; 94:267–271.
Article
26. Sangild PT. Gut responses to enteral nutrition in preterm infants and animals. Exp Biol Med (Maywood). 2006; 231:1695–1711.
Article
27. Kim YJ. Enteral nutrition and its clinical application. Korean J Pediatr Gastroenterol Nutr. 2009; 12:Suppl 1. S27–S36.
Article
28. Wu G, Jaeger LA, Bazer FW, Rhoads JM. Arginine deficiency in preterm infants: biochemical mechanisms and nutritional implications. J Nutr Biochem. 2004; 15:442–451.
Article
29. Buddington RK, Elnif J, Puchal-Gardiner AA, Sangild PT. Intestinal apical amino acid absorption during development of the pig. Am J Physiol Regul Integr Comp Physiol. 2001; 280:R241–R247.
Article
30. Bjornvad CR, Schmidt M, Petersen YM, Jensen SK, Offenberg H, Elnif J, et al. Preterm birth makes the immature intestine sensitive to feeding-induced intestinal atrophy. Am J Physiol Regul Integr Comp Physiol. 2005; 289:R1212–R1222.
Article
31. Rigo J, Salle BL, Picaud JC, Putet G, Senterre J. Nutritional evaluation of protein hydrolysate formulas. Eur J Clin Nutr. 1995; 49:Suppl 1. S26–S38.
32. Szajewska H, Albrecht P, Stoitiska B, Prochowska A, Gawecka A, Laskowska-Klita T. Extensive and partial protein hydrolysate preterm formulas: the effect on growth rate, protein metabolism indices, and plasma amino acid concentrations. J Pediatr Gastroenterol Nutr. 2001; 32:303–309.
Article
33. Zuppa AA, Visintini F, Cota F, Maggio L, Romagnoli C, Tortorolo G. Hydrolysed milk in preterm infants: an open problem. Acta Paediatr Suppl. 2005; 94:84–86.
Article